RxDoctor Payments Data

Kyle Christensen, DO

Surgery · Bridgeton, MONPI 1164804035

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (58.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $3,767 and has fallen 87.9% since, to $457 in 2025.

$6,897in general payments, 2019–2025

Across 80 payments — averaging $86.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Smith+Nephew$352
  • Kerecis Limited$157
  • AbbVie$111
  • Acera Surgical, Inc.$90
  • Johnson & Johnson$90
  • plus $382 from 10 others

What the payments were for

  • Travel & lodging$72511%
  • Food & beverage$2,17131%
  • Education$4,00058%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,897 in reported general payments places this provider in the 75th percentile of 612 surgery providers in Missouri.

See all surgery providers in Missouri →

Medicare billing

Part B allowed, 2024
$87,576
Medicare patients
166
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.33$81,777
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$434
Ibuprofen45$150
Tramadol Hcl14$23

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$352$81,77733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 612 surgery providers in Missouri.

Other surgery in Bridgeton

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →